ArticlePharmaceuticals (Basel, Switzerland)2019

Metabolism and Pharmacokinetic Study of the Boron-Containing Prodrug of Belinostat (ZL277), a Pan HDAC Inhibitor with Enhanced Bioavailability.

Changde Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.